ERβ expression was found to decline in primary ovarian epithelial tumors compared to normal ovarian tissue as it has been shown in breast, colon, and prostate cancer [43,44,45,46,47,48,49,50,51,52,53]. The gene discussed is ESR2; the disease is prostate cancer.